Bath & Body Works Affirms FY2026 Adj EPS Guidance of $2.60-$2.80 vs $2.74 Est; Raises FY2026 Sales Guidance from $6.999B-$7.109B to $7.043B-$7.138B vs $7.105B Est
Benzinga Newsdesk 1 day ago
NewsGuidance
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Bath & Body Works (NYSE:BBWI) affirms FY2026 Adj EPS guidance from $2.60-$2.80 to $2.60-$2.80 vs $2.74 analyst estimate. Raises FY2026 sales outlook from $6.999 billion-$7.109 billion to $7.043 billion-$7.138
More on BBWI
Analyst ratings Benzinga
UBS Maintains Neutral on Bath & Body Works, Lowers Price Target to $19UBS analyst Jay Sole maintains Bath & Body Works (NYSE:BBWI) with a Neutral and lowers the price target from $22 to $19.
Analyst ratings Benzinga
JP Morgan Maintains Neutral on Bath & Body Works, Lowers Price Target to $23JP Morgan analyst Matthew Boss maintains Bath & Body Works (NYSE:BBWI) with a Neutral and lowers the price target from $24 to $23.
Analyst ratings Benzinga
B of A Securities Maintains Buy on Bath & Body Works, Lowers Price Target to $25B of A Securities analyst Lorraine Hutchinson maintains Bath & Body Works (NYSE:BBWI) with a Buy and lowers the price target from $30 to $25.
Earnings Benzinga
Bath & Body Works Analysts Slash Their Forecasts After Q3 EarningsBath & Body Works beat Q3 estimates and raised FY26 sales outlook, but cut GAAP EPS guidance and gave weak Q4 forecasts; analysts lowered price targets.

Analyst ratings Benzinga
BMO Capital Maintains Market Perform on Bath & Body Works, Lowers Price Target to $20BMO Capital analyst Kelly Crago maintains Bath & Body Works (NYSE:BBWI) with a Market Perform and lowers the price target from $24 to $20.
Analyst ratings Benzinga
Wells Fargo Maintains Overweight on Bath & Body Works, Lowers Price Target to $24Wells Fargo analyst Ike Boruchow maintains Bath & Body Works (NYSE:BBWI) with a Overweight and lowers the price target from $25 to $24.
